SOURCE: StockCall


December 06, 2010 08:42 ET

Research on Cardinal Health Inc. and McKesson Corp. - Drug Wholesalers on Acquisition Spree

JOHANNESBURG, SOUTH AFRICA--(Marketwire - December 6, 2010) - offers investors comprehensive research on the drugs wholesale industry and has completed analytical research on Cardinal Health Inc. (NYSE: CAH) and McKesson Corp. (NYSE: MCK). Register with us today at to have free access to these researches. 

Acquisitions have been the name of the game in the Drug Wholesale sector lately. One primary area of acquisition has been China where Cardinal Health Inc. is working to gain a foothold in the drug distribution market. One of the major motivators of expansion into this emerging market is the forecast that the Chinese pharmaceutical industry is going to grow 20% annually until it is the second biggest pharmaceutical market in the world after the United States in 2015. Whilst Cardinal Health has certainly opened the path towards overseas expansion, it would be long when others like McKesson Corp. for instance would follow suit. Investors can register for free to access the research reports on Cardinal Health Inc. and McKesson Corp. at or is an online platform where investors doing their due-diligence on the drugs wholesale industry can have easy and free access to our analyst research and opinions on Cardinal Health Inc. and McKesson Corp.; investors and shareholders of these companies can simply register for a complimentary membership at

Elsewhere, companies are working to expand their presence in independent pharmacies. While larger customers like Walgreens represent the largest portion of their business, some companies are trying to gain ground with smaller pharmacies due to the higher margins they get selling their drugs to them. Visit to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

Consolidation within the industry as well as the increased scale gained by growth overseas should help wholesalers in their price negotiations with drug makers. This could be partially offset by the negative price effects of intra-industry competition. Register now at to have free access to our reports on the drugs wholesale industry.

About is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information